Emergent Product Development Gaithersburg Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Sep 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 23, 2027The maintenance fee for Temperature Stable Vaccine Formulations (US 10,357,559) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
- 1 fee due Apr 1, 2027The maintenance fee for Iminosugars Useful for the Treatment of Viral Diseases (US 10,428,022) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for 2-Pyridone Antimicrobial Compositions (US 10,517,865) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,962,842 | 2-Pyridone Antimicrobial Compositions In force · High confidence | In force | High confidence | |
| US 10,517,865 | 2-Pyridone Antimicrobial Compositions In force · Medium confidence | In force | Medium confidence | |
| US 10,155,021 | Antimicrobial 4-Oxoquinolizines In force · Low confidence | In force | Low confidence | |
| US 10,357,559 | Temperature Stable Vaccine Formulations In force · High confidence | In force | High confidence | |
| US 10,144,727 | Deoxynojirimycin Derivatives and Methods of Their Using In force · High confidence | In force | High confidence | |
| US 10,428,022 | Iminosugars Useful for the Treatment of Viral Diseases In force · High confidence | In force | High confidence | |
| US D957,624 | Autoinjector In force · High confidence | In force | High confidence | |
| US D965,767 | Autoinjector In force · From the USPTO record | In force | From the USPTO record | |
| US 12,702,646 | Microsphere Formulations Comprising Nalmefene and Methods for Making and Using the Same In force · High confidence | In force | High confidence | |
| US 12,673,924 | Valiolamine Derivatives as Glucosidase Inhibitors In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 1 patent in force now held by others · 24 lapsed for an unpaid fee · 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 1 abandoned · 9 no status recorded